WHAT YOU NEED TO KNOW
- CVS plans to separate into 2 independent, publicly traded companies during the first half of 2028.
- CVS Health would retain Aetna, CVS Caremark, CVS Specialty, Oak Street Health, and Signify Health.
- CVS Pharmacy would include approximately 9,000 retail pharmacy locations, MinuteClinic locations, and other services.
- Third quarter revenue rose 5.4% to $108.4 billion, while adjusted earnings reached $2.09 per share.
- CVS shares fell roughly 9% Wednesday despite higher full year 2026 adjusted earnings guidance.
DISCLAIMER: GoldInvestors.news is not a registered investment, legal or tax advisor or broker/dealer. All investment/financial opinions expressed by GoldInvestors.news are from the personal research and experience of the owner of the site and are intended as educational material. Although best efforts are made to ensure that all information is accurate and up to date, occasionally unintended errors and misprints may occur.
CVS Health Corporation announced a sweeping plan Wednesday to separate its operations into 2 independent, publicly traded companies. The move would reshape one of the largest healthcare companies in the United States and reverse its long term strategy of operating several major businesses under a single corporate structure.
Investors responded sharply to the announcement and the company’s latest financial report. CVS shares fell roughly 9% on Wednesday after the company also released its third quarter results.
The proposed separation would divide CVS Health’s insurance, pharmacy benefit management, and healthcare services operations from its retail pharmacy and community healthcare segments. Each business would have greater independence while remaining able to pursue partnerships across the healthcare industry.
One of the 2 companies would retain the CVS Health name. That company would contain Aetna, CVS Caremark, CVS Specialty, Oak Street Health, and Signify Health, placing the insurance, pharmacy benefit management, and healthcare services operations together.
The second company would operate under the CVS Pharmacy name. It would include approximately 9,000 retail pharmacy locations, MinuteClinic locations, and other services associated with the company’s retail pharmacy and community healthcare operations.
The structure would give each organization control over its own operations as a separate public company. Management believes this independence would allow the businesses to operate more effectively while preserving their ability to work with partners throughout the healthcare industry.
The planned split represents a major departure from CVS Health’s previous corporate approach. The company had pursued a long term strategy that brought insurance, pharmacy benefit management, healthcare services, retail pharmacy, and community healthcare into one broad organization.
Under the new plan, those operations would no longer sit within the same publicly traded company. CVS Health would focus on Aetna and its collection of pharmacy benefit management and healthcare services businesses, while CVS Pharmacy would house the retail network and MinuteClinic locations.
The separation is expected to be completed in the first half of 2028. Until then, CVS is moving forward with a plan that requires dividing a large collection of healthcare operations into 2 distinct public companies.
The announcement arrived alongside quarterly financial results showing continued revenue growth. CVS reported total third quarter revenue of $108.4 billion, an increase of 5.4% from $102.9 billion during the same period a year earlier.
Adjusted earnings per share also improved during the quarter. The company reported adjusted earnings of $2.09 per share, up from $1.60 per share in the previous year period.
Following that performance, CVS raised its financial guidance for the full year of 2026. The company now expects adjusted earnings per share of at least $8.20, compared with its previous forecast range of $7.90 to $8.10.
The stronger guidance accompanied a roughly 9% decline in CVS shares Wednesday. The market reaction came as investors weighed both the latest quarterly performance and a corporate separation expected to take until the first half of 2028 to complete.
For CVS Health, the proposal draws a clear boundary between businesses that had been assembled within one corporate framework. Aetna, CVS Caremark, CVS Specialty, Oak Street Health, and Signify Health would remain with the company bearing the CVS Health name.
CVS Pharmacy, meanwhile, would emerge as a separate publicly traded operator with approximately 9,000 retail locations and MinuteClinic locations. The plan would place the company’s extensive physical pharmacy presence outside the organization containing Aetna and the other listed healthcare services businesses.
Management’s stated case for the separation centers on independence and flexibility. While the 2 organizations would operate separately, the proposal is designed to preserve opportunities for partnerships across the healthcare industry after the split is completed.
The expected completion date leaves CVS with a lengthy process before the new structure takes effect. For now, the company has paired a dramatic corporate restructuring proposal with higher 2026 earnings guidance and third quarter growth in both revenue and adjusted earnings per share.
DISCLAIMER: GoldInvestors.news is not a registered investment, legal or tax advisor or broker/dealer. All investment/financial opinions expressed by GoldInvestors.news are from the personal research and experience of the owner of the site and are intended as educational material. Although best efforts are made to ensure that all information is accurate and up to date, occasionally unintended errors and misprints may occur.
Join the Discussion
COMMENTS POLICY: We have no tolerance for messages of violence, racism, vulgarity, obscenity or other such discourteous behavior. Thank you for contributing to a respectful and useful online dialogue.